3 results
Approved WMOWill not start
The primary objectives of this study are to establish the efficacy and safety of APL-2 compared to eculizumab in patients with PNH who continue to have Hb levels <10.5 g/dL despite treatment with eculizumab.
Approved WMOCompleted
The present study aims to initiate the testing of a new, curative, person-directed, approach of patients with burnout, that uses neurofeedback, also called EEG (electroencephalogram)-biofeedback.
Approved WMORecruiting
Stratum 1:To show that a non total body irradiation (TBI) containing conditioning (Flu/Thio/ivBu) results in a non inferior survival as compared to conditioning with TBI/Etoposide in children older than 4 years after HSCT from a Human leucocyte…